SLC3A2 Silencing Alleviates Aortic Dissection via cAMP‐PKA Activation and Disulfidptosis Inhibition
Aortic dissection (AD) is a life-threatening cardiovascular emergency. Disulfidptosis, a novel disulfide stress-induced cell death, remains unexplored in AD. We investigated whether solute carrier family 3 member 2 (SLC3A2), a disulfidptosis-related gene, contributes to AD pathogenesis. Bioinformatic analyses of Gene Expression Omnibus datasets combined machine learning algorithms to identify SLC3A2 as a core gene. A murine AD model was established using β-aminopropionitrile and angiotensin II, with lentiviral knockdown of SLC3A2. Human aortic vascular smooth muscle cells (HAVSMCs) were challenged with BAY-876 to induce disulfidptosis. Histological staining evaluated medial degeneration and elastic fiber integrity. Disulfidptosis was assessed by measuring cystine accumulation and the protein expression of filamin A (FLNA) and NCK-associated protein 1 (NCKAP1). The involvement of cyclic adenosine monophosphate (cAMP)-protein kinase A (PKA) signaling was verified by genetic knockdown of its catalytic subunit (PRKACA). We observed SLC3A2 was upregulated in AD. SLC3A2 knockdown delayed lethal aortic rupture, reduced aortic medial degeneration, decreased reactive oxygen species and cystine, while restoring glutathione and free thiols. In HAVSMCs, SLC3A2 silencing preserved filamentous actin integrity, reversed the BAY-876-induced downregulation of α-smooth muscle actin and smooth muscle 22 alpha, and restored the aberrant expression of FLNA and NCKAP1. Mechanistically, SLC3A2 knockdown reactivated the cAMP-PKA signaling axis suppressed by BAY-876, and PRKACA knockdown abrogated the protective effects of SLC3A2 silencing on oxidative stress, cytoskeletal integrity, and disulfidptosis. In conclusion, SLC3A2 drives AD progression by suppressing cAMP-PKA signaling, thereby exacerbating oxidative stress and disulfidptotic cytoskeletal collapse. Targeting the SLC3A2/cAMP-PKA axis represents a promising therapeutic strategy for AD.
Authors
- Zhigao Song (ORCID: https://orcid.org/0000-0001-5416-3866)
- Shenghui Bi (ORCID: https://orcid.org/0009-0003-0470-4427)
- Jiahong Xie
- Lugang Mei
- Yaling Li (ORCID: https://orcid.org/0009-0001-1830-5051)
- Xiaowu Wang
- Xuefei Yu
- Jinli Lin
Institutions
- Zhujiang Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- The FASEB Journal
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1096/fj.202604022r
- Primary Topic
- Aortic Disease and Treatment Approaches
- Type
- article
- Field-Weighted Citation Impact
- 0.00